# Prophylactic Use of Timolol Maleate to Prevent Intraocular Pressure Elevation After Nd:YAG Laser Posterior Capsulotomy

> **NCT07729189** · NA · COMPLETED · sponsor: **CMH Multan Institute of Medical Sciences** · enrollment: 210 (actual)

## Conditions studied

- Capsule Opacification
- Ocular Hypertension

## Interventions

- **DRUG:** Timolol Maleate
- **DRUG:** No intervention

## Key facts

- **NCT ID:** NCT07729189
- **Lead sponsor:** CMH Multan Institute of Medical Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-10
- **Primary completion:** 2025-09-10
- **Final completion:** 2025-09-10
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07729189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07729189, "Prophylactic Use of Timolol Maleate to Prevent Intraocular Pressure Elevation After Nd:YAG Laser Posterior Capsulotomy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07729189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*